SCHEMBL30954067

SCHEMBL30954067

COc1ccc(CN2CCOc3c2cc(Cl)c(OC)c3C(=O)O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.42
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
HDAC1 Q13547 3/20 0.39
HDAC6 Q9UBN7 3/20 0.39
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC9 Q9UKV0 1/20 0.39
HDAC5 Q9UQL6 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HSD17B10 Q99714 1/20 0.39
SIRT2 Q8IXJ6 1/20 0.39
SIRT1 Q96EB6 1/20 0.39
MAPT P10636 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27435254 1.00 TP53 (0.42) TP53MEN1KMT2AHDAC1HDAC6
SCHEMBL27435528 0.92 KCNA3 (0.41) TP53KDM4EALDH1A1HSD17B10CCR2
SCHEMBL30954057 0.91 TP53 (0.40) TP53MEN1KMT2AKDM4EALDH1A1
SCHEMBL27434671 0.91 TP53 (0.40) TP53MEN1KMT2AKDM4EALDH1A1
SCHEMBL27435244 0.91 TP53 (0.43) TP53MEN1KMT2AHDAC1HDAC6
SCHEMBL30954048 0.86 ALDH1A1 (0.36) MEN1KMT2AKDM4EALDH1A1HSD17B10
SCHEMBL27435420 0.86 ALDH1A1 (0.36) MEN1KMT2AKDM4EALDH1A1HSD17B10
SCHEMBL30954160 0.85 KDM4E (0.40) TP53MEN1KMT2AKDM4EALDH1A1
SCHEMBL27435335 0.85 KDM4E (0.40) TP53MEN1KMT2AKDM4EALDH1A1
SCHEMBL27435508 0.83 DRD3 (0.41) TP53MEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630412-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD Pharma A/S (DK) 2025-10-15 EP claimed
WO-2024121130-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 WO claimed
EP-4630412-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD Pharma A/S (DK) 2025-10-15 EP disclosed
WO-2024121130-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 WO disclosed